Basic Apo Hydro Information

• INN (International Nonproprietary Name): Hydrochlorothiazide (INN: Hydrochlorothiazidum).
• Brand Names Available In Canada (English): Microzide; Aquazide H; Hydrochlorothiazide (generic); Hydrodiuril; Hydrocot/Inzirqo/Zide — availability by brand in Canada not specified in supplied data.
• ATC Code: C03AA03 (Thiazide diuretics, plain).
• Forms & Dosages: Capsules 12.5 mg; Tablets 12.5 mg, 25 mg, 50 mg; Powder for suspension/solution — exact Canadian formulations not specified.
• Manufacturers In Canada (English): Manufacturers listed in supplied data include Mylan, Teva, Sandoz, Stada, Accord, Torrent and Cipla; specific Canadian manufacturers or licensees not specified.
• Registration Status In Canada (English): Not specified in supplied data.
• OTC / Rx Classification: Prescription only (Rx) in regions reviewed; not available OTC.

Latest Research Highlights — Canadian And International

Are you wondering what recent studies say about thiazide optimisation for older adults with systolic hypertension?

Recent trials from 2022–2025 have focused on optimising thiazide-class therapy and on renal‑friendly regimens for people with multimorbidity, with meta‑analyses continuing to support thiazides as first‑line agents in older adults with hypertension.

Clinical trial signals often contrast chlorthalidone's longer duration with hydrochlorothiazide's tolerability and use in fixed‑dose combinations, while pharmacokinetic notes remain consistent: onset ≈2 hours, peak ≈4 hours, duration ≈24 hours.

Canadian cohort work emphasises routine monitoring of electrolytes and renal function in older adults and people with multiple conditions, and documents access and follow‑up gaps in Indigenous and rural cohorts.

For a one‑line summary clinicians can offer patients: thiazide diuretics such as hydrochlorothiazide effectively lower systolic blood pressure in older adults, but monitoring for low potassium, low sodium and kidney function is required early after starting or changing dose.

Research gaps include large Canada‑specific randomized trials directly comparing hydrochlorothiazide versus chlorthalidone in Indigenous or remote populations.

Clinical Effectiveness In Canada

Do thiazides actually work for the mild‑to‑moderate hypertension seen in primary care?

Health Canada‑approved hydrochlorothiazide products are listed across provincial formularies with variable listing statuses and reimbursement tiers.

Clinically, hydrochlorothiazide is effective for Stage 1–2 hypertension and for mild‑to‑moderate oedema, with typical adult doses for hypertension of 12.5–25 mg once daily and higher or divided doses for oedema.

DINs are manufacturer‑specific; when referencing a brand in writing, cite the product DIN as assigned by Health Canada when available.

• Approved Indication — DIN — Formulation: Not specified by product in supplied data; writers should list DINs per brand when the specific product is cited.

Provincial context: Ontario Drug Benefit, BC PharmaCare and RAMQ include thiazide options, but coverage tiers and prior‑authorization rules differ by province.

Clinical monitoring should include baseline electrolytes and creatinine, with repeat tests within 1–2 weeks after starting or changing dose.

Patient leaflets and labels in Canada must be bilingual; include an English/French note on monitoring and symptoms such as dizziness or muscle cramps.

Indications And Expanded Uses

Want to know when pharmacists and prescribers use HCTZ beyond routine blood pressure control?

Approved indications in Canada align with international practice and include hypertension and treatment of volume overload or oedema.

Off‑label uses seen in practice include low‑dose thiazides for prevention of calcium kidney stones in hypercalciuria, modulation of calcium metabolism, and as an adjunct in combination regimens for resistant hypertension.

• Approved: Hypertension; Oedema — monitor electrolytes and renal function.
• Off‑Label: Nephrolithiasis prevention for hypercalciuria; Combination therapy in resistant hypertension — document informed consent and involve a specialist as needed.

Special populations such as pregnant or breastfeeding people are flagged as relative contraindications; consult obstetrics and Health Canada monographs before prescribing.

Clinicians should document informed consent for off‑label use and provide bilingual patient information sheets.

Composition And Brand Landscape

Are there many pack options and brands for hydrochlorothiazide in Canada?

The active ingredient is hydrochlorothiazide (INN: Hydrochlorothiazidum).

The Canadian market includes generics and branded generics; Apotex‑style “Apo‑” formulations are commonly stocked at major chains, though specific DINs and exact brand lists in Canada are not specified in supplied data.

Generics offer cost savings and must meet Health Canada bioequivalence standards before approval.

Packaging in Canada must include bilingual English/French patient directions and a visible DIN on the label.

Common pack sizes include blister packs of 10 or 28 and bottles of 30 or 100 tablets; rural pharmacies may stock fewer pack size options than urban chains.

Contraindications And Special Precautions

Who should not take hydrochlorothiazide, and who needs closer monitoring?

Absolute contraindications include anuria and known hypersensitivity to hydrochlorothiazide or sulfonamide derivatives.

Co‑administration with dofetilide or lithium is contraindicated because of severe interactions.

• Absolute Contraindications: Anuria; hypersensitivity to HCTZ or sulfonamides; concurrent dofetilide or lithium.
• High‑Risk Monitoring Actions: Check baseline electrolytes and creatinine; repeat within 1–2 weeks; more frequent checks for elderly and those with eGFR <30 mL/min.

Relative precautions include gout, diabetes (possible impairment of glucose tolerance), hepatic impairment, and renal dysfunction.

High‑risk Canadian groups include elderly patients on multiple medications, people in remote Indigenous communities with limited lab access, and individuals facing food insecurity that may affect dietary potassium intake.

Pharmacists should flag contraindications at dispensing and recommend monitoring schedules, using bilingual counselling materials for clarity.

Dosage Guidelines

How should hydrochlorothiazide be dosed across different patient groups?

Standard adult dosing for hypertension in Canada is 12.5–25 mg once daily, and for oedema 25–100 mg per day in 1–2 divided doses.

Children require specialist supervision and weight‑based dosing, often around 1–2 mg/kg as guided by a paediatrician.

Elderly patients should start at the lowest possible dose and have electrolytes and renal function monitored more frequently.

• Missed Dose: Take as soon as you remember unless near the next dose; do not double up.
• Overdose: Seek emergency care for severe hypotension or electrolyte disturbances.

Many prescribers advise morning dosing to reduce nocturia and improve adherence.

Interactions Overview

Worried that HCTZ will clash with other medicines you take?

Certain interactions are clinically serious and must be checked before dispensing.

• Major Drug Interactions (Action Required): Lithium (increased lithium levels); Dofetilide (contraindicated due to arrhythmia risk); ACE inhibitor/ARB combinations (potentiation of renal effects and hypotension); NSAIDs (may blunt diuretic effect and worsen renal function).
• Lifestyle Interactions: High‑sodium diets common in Canada can blunt effect; alcohol increases risk of orthostatic hypotension.

Thiazides often work well with ACE inhibitors or ARBs as combination therapy but require close monitoring for blood pressure and kidney function changes.

Pharmacists should use drug‑interaction databases and provincial e‑health records to flag interactions and advise on monitoring.

Cultural Perceptions And Patient Habits

What do Canadian patients say about “water pills” and how does that shape adherence?

Many patients call hydrochlorothiazide a “water pill” and worry about frequent urination affecting work or travel, which can reduce adherence.

Online forums and provincial patient groups frequently raise concerns about daytime polyuria, electrolyte side effects, and cost anxiety even where public coverage exists.

• Patient Concerns: Daytime urination, dizziness, low potassium, cost, and lab access in rural communities.
• Pharmacist Counselling Prompts: Suggest morning dosing, discuss signs of low electrolytes, review coverage, and arrange timely lab access.

Rural and Indigenous communities often report pharmacy access and lab monitoring challenges; bilingual labelling and culturally safe counselling improve uptake and understanding.

Some Canadians consider cross‑border purchases or online pharmacies; pharmacists should counsel patients to verify product authenticity and the DIN before purchase.

Availability And Pricing Patterns

How easy is it to find HCTZ in Canadian pharmacies and what will it cost?

Hydrochlorothiazide is widely stocked at national chains like Shoppers Drug Mart, Rexall, London Drugs and Jean Coutu, and at many independents; online Canadian pharmacies require prescription and DIN verification.

Generics typically provide the greatest savings, and provincial coverage varies by formulary and prior approval rules.

Rural pharmacies may have limited stock and longer restock timelines; mail‑order and provincial distribution programs can help bridge gaps.

In our online pharmacy, apo hydro is available without a prescription, with discreet delivery to Canada (English) in 5-14 days.

Comparable Medicines And Preferences

Which alternative diuretics might a prescriber choose instead of HCTZ?

Alternatives available in Canada include chlorthalidone, indapamide and loop diuretics such as furosemide for more severe oedema.

Chlorthalidone may show longer duration and greater BP reduction in some trials, while indapamide is sometimes chosen for a more favourable metabolic profile.

• Pros/Cons Checklist: HCTZ—well tolerated and in many fixed combinations; Chlorthalidone—longer action but may have more metabolic effects; Indapamide—favoured for metabolic neutrality in some patients; Furosemide—preferred for significant fluid overload.

Combination products (ACEi/HCTZ or ARB/HCTZ) simplify regimens and can improve adherence, but formulary reimbursement differs by province and by DIN.

Prescribers consider renal function, electrolyte tolerance, fracture risk in the elderly and co‑morbidities such as diabetes or gout when selecting an agent.

FAQ — Canadian Patient Style Q&A

• Q: Will this water pill make me pee all day?
• A: Increased urination is common at the start; taking HCTZ in the morning cuts down on night‑time trips to the bathroom.
• Q: Do I need blood tests?
• A: Yes — baseline electrolytes and kidney function, repeat within 1–2 weeks, and periodic monitoring afterwards.
• Q: Will the drug interact with my other meds?
• A: Important interactions include lithium and dofetilide; NSAIDs and some antihypertensives also interact — show your pharmacist all medicines and supplements.
• Q: Is it covered by my provincial plan?
• A: Coverage varies — check ODB/PharmaCare/RAMQ or your private insurer; generics usually cost less.
• Q: Can I buy it over the border?
• A: Cross‑border purchases occur, but check authenticity and DIN and be aware of importation rules.

Ask the dispensing pharmacist for a bilingual (English/French) leaflet and local lab appointment guidance if you need monitoring.

Guidelines For Proper Use — Pharmacist And Provincial Tips

What should pharmacists check before dispensing HCTZ and how can provinces help with access?

Pharmacist action points include verifying indication, checking the product DIN, counselling on timing (morning dosing), reviewing all medications for interactions, and scheduling baseline and follow‑up labs.

• Dispensing Checklist: verify pregnancy/breastfeeding status, confirm baseline labs, screen for concurrent lithium or dofetilide, confirm sulfonamide allergy, document indication and provide bilingual counselling.

Provincial programs such as ODB and PharmaCare may require specific forms or prior approvals for certain strengths or combination products; check DIN‑based listings before substitution.

For remote patients, arrange local lab draws, consider safe longer prescription durations, and use mail‑order pharmacy services with temperature‑stable packaging.

Culturally safe practice includes bilingual materials, involving family caregivers with consent, and liaising with Indigenous health centres when appropriate.

Storage guidance: store products at 20–25°C and protect from heat and moisture as per product guidance.

Delivery Across Canada (English)